Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 2.330% | 11.458% | -2.727% | 151.765% | 28.916% | 9.184% | -65.203% |
| Northwest Biotherapeutics Inc. | 0.000% | -7.895% | -12.500% | -8.377% | -15.049% | -67.593% | -84.649% |
| Celldex Therapeutics | 8.470% | 5.078% | 7.600% | 103.788% | 22.273% | -9.732% | 54.243% |
Comments
News
Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares?
Gregory T. Lucier, a member of the Board of Directors of Dentsply Sirona (NASDAQ:XRAY), reported the purchase of 15,000 shares of common stock at an average price of $12.45 per share on March 9
